HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Harbor MedTech Inc. in Irvine raised $5 million in equity funding from three investors as part of an unfinished $8.5 million effort, a regulatory filing said.
ICU Medical Inc. in San Clemente said it would buy New York-based Pfizer Inc.’s infusion therapy division in a cash-and-stock deal valued at $1 billion.
Griffin-American Healthcare REIT IV Inc. in Irvine bought two medical office buildings, one each in Michigan and Alabama, for a combined $25 million.
Orange-based Merical Inc. has been acquired on undisclosed terms by private-equity firm Linden Capital Partners LLC in Chicago.
Masimo Corp. Chief Executive Joe Kiani co-led a $24 million equity investment in Stereotaxis Inc. that could be worth as much as $50 million.
The Hass Avocado Board in Mission Viejo formed a four-year partnership with the American Heart Association “to galvanize Americans to eat the recommended amounts of fruits and vegetables every day.”
Frost Data Capital in San Juan Capistrano will work with DST Systems Inc. in Kansas City, Mo., on big data analysis for healthcare companies.
Ensign Group Inc. in Mission Viejo plans to sell 16 urgent care facilities that are open or in development in the Seattle market to MultiCare Health System in Tacoma, Wash.
Allergan Plc’s local operations provide 1,563 jobs here with a combined payroll of about $307 million, based on the company’s average salary statewide, an economic impact study said.
Carrick Capital Partners in Newport Beach has invested $50 million in InstaMed in Philadelphia.
OCTANe in Aliso Viejo will merge with Orange County Technology Alliance in Mission Viejo.
Johnson & Johnson in New Brunswick, N.J. will buy Abbott Medical Optics in Santa Ana for $4.3 billion in cash. The deal is expected to close early next year.
Aerie Pharmaceuticals Inc. plans to offer $125 million in stock next week.
Chapman University’s School of Pharmacy has opened its first center, which focuses on targeted drug delivery.
Allergan Plc will buy Vitae Pharmaceuticals Inc. for about $639 million.